РЕЗЮМЕ
Цель данного исследования — оценить влияние терапии радиоактивным йодом на качество жизни пациентов с болезнью Грейвса и токсической аденомой. Таким образом, терапия радиоактивным йодом оказывает положительное влияние не только на гормональный статус, но и на психосоциальное состояние пациентов. Использование шкал, таких как ThyPRO-39, рекомендовано для комплексного клинического мониторинга.
Keywords: болезнь Грейвса, токсическая аденома, показатель качества жизни

---

ЛИТЕРАТУРА

1. Ajjan RA, Weetman AP, Dayan CM. Management of Graves’ disease: A review // Nature Reviews Endocrinology. 2021;17(11):724-736. doi: 10.1038/s41574-021-00563-2.
2. Bednarczuk T, Brix TH, Schima W, Zettinig G, et al. 2021 European Thyroid Association Guidelines for the Management of Iodine-Based Contrast Media-Induced Thyroid Dysfunction // Eur Thyroid J. 2021 Jul;10(4):269-284. doi: 10.1159/000517175.
3. El Fassi D, Brix TH. Quality of life following radioiodine therapy in hyperthyroid patients: What matters most? // Endocrine Connections. 2022;11(2):e210476. doi: 10.1530/EC-21-0476.
4. Kanokwongnuwat W, Penpong N. Prospective study to evaluate radioactive iodine of 20 mCi vs 10-15 mCi in Graves’ disease // BMC Endocrine Disorders. 2024;24:54. doi: 10.1186/s12902-024-01588-3.
5. Lee SY., Ryu MJ, Kim HJ. Impact of radioactive iodine therapy on the quality of life in patients with Graves’ disease // Frontiers in Endocrinology. 2021;12:678792. doi: 10.3389/fendo.2021.678792.
6. Li Y, Yang T, Ju L, Wang Z. Quality of life and decision regret in patients with late-hypothyroidism after radioiodine treatment for Graves’ disease // Clinical Endocrinology (Oxford). 2024;100(1):87-95. doi: 10.1111/cen.14986.
7. Mooij CF, Cheetham TD, Verburg FA, Eckstein A, et al. 2022 European Thyroid Association Guideline for the management of pediatric Graves' disease // Eur Thyroid J. 2022 Jan 1;11(1):e210073. doi: 10.1530/ETJ-21-0073.
8. Nilsson JN, Elovsson R, Thor D, Calissendorff J, et al. Radioiodine treatment outcome by dosimetric parameters and renal function in hyperthyroidism // Thyroid Research. 2022;15:8. doi: 10.1186/s13044-022-00126-4.
9. Rigó A, Malkov K, Szabó A, Bognár VK, et al. Adaptation and validation of the Hungarian version of Thyroid-Related Patient-Reported Outcome-39 (ThyPro-39) questionnaire: testing factor structure, known-group validity with the comparison of quality of life in Hashimoto's thyroiditis and Graves' disease // J Patient Rep Outcomes. 2023 Jun 27;7(1):60. doi: 10.1186/s41687-023-00606-7.
10. Taprogge J, Gape PM, Carnegie-Peake L. A systematic review and meta-analysis of the relationship between the radiation absorbed dose to the thyroid and response in patients treated with radioiodine for Graves’ disease // Thyroid. 2021;31(12):1829-1838. doi: 10.1089/thy.2021.0302.